Yangtze River Pharmaceutical Group (YRPG) Visits YAFO Office to Discuss Cross-boarder Opportunities
On June 3rd, 2019, Mr. Cai Wei, the head of R&D Center of Yangtze River Pharmaceutical Group(YRPG), visited YAFO Capital Shanghai office with its team. YRPG has ranked No. 1 for many years among all Chinese pharmaceutical companies (Data reported by China Ministry of Industry and Information Technology).
Yangtze River Pharmaceutical Group (YRPG) Visits YAFO Office to Discuss Cross-boarder Opportunities
On June 3rd, 2019, Mr. Cai Wei, the head of R&D Center of Yangtze River Pharmaceutical Group(YRPG), visited YAFO Capital Shanghai office with its team. YRPG has ranked No. 1 for many years among all Chinese pharmaceutical companies (Data reported by China Ministry of Industry and Information Technology).
Mr. Cai introduced YRPG’s corporate, especially its cross-border strategies of investment, licensing and business cooperation model. Fan Zheng, Managing Director of YAFO Life Science, shared YAFO’s current pipelines and strengths in cross-boarder transactions. YRPG team and YAFO Life Science team discussed potential cross border cooperation opportunities, and how YAFO Life Science team can help YRPG speed up their innovation pipeline.
About Yangtze River Pharmaceutical Group (YRPG)
Founded in 1971, YRPG is a national giant cross-regional pharmaceutical group, integrating with research, manufacturing and trading. It is listed as the No. 1 Innovative Enterprises by China MIIT. YRPG has over 13,000 employees. Over 20 subsidiaries are located in Beijing, Shanghai, Nanjing, Guangzhou etc. The sales network covers all over China. According to the data published by MIIT, YRPG took the first place in TOP 100 enterprises of Chinese pharmaceutical industry in 2010, 2014 and 2015, and has ranked No. 1 in Chinese chemical pharmaceutical Industry for consecutive 4 years. Other corporate highlights:
Top 3 China Pharmaceutical Group
TOP China 500 Companies
Marketed products in more than 10 fields and involved in 20 dosage forms and 200 types
over 2 million sq.m Facilities
500+ R&D personnel